MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
22.46
-0.44 (-1.92%)
Nov 1, 2024, 4:00 PM EDT - Market closed

MBX Biosciences Statistics

Total Valuation

MBX has a market cap or net worth of $749.80 million. The enterprise value is $847.14 million.

Market Cap 749.80M
Enterprise Value 847.14M

Important Dates

The next estimated earnings date is Saturday, November 16, 2024, before market open.

Earnings Date Nov 16, 2024
Ex-Dividend Date n/a

Share Statistics

MBX has 33.38 million shares outstanding.

Shares Outstanding 33.38M
Shares Change (YoY) n/a
Shares Change (QoQ) +4.50%
Owned by Insiders (%) 2.99%
Owned by Institutions (%) 7.65%
Float 13.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.17, with a Debt / Equity ratio of 0.00.

Current Ratio 7.17
Quick Ratio 6.76
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$1.75M
Employee Count 27
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 48.31
Average Volume (20 Days) 112,735

Short Selling Information

The latest short interest is 311,843, so 0.93% of the outstanding shares have been sold short.

Short Interest 311,843
Short Previous Month 363,738
Short % of Shares Out 0.93%
Short % of Float 2.26%
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -50.91M
Pretax Income -47.20M
Net Income -47.20M
EBITDA -50.72M
EBIT -50.91M
Earnings Per Share (EPS) -$3.35
Full Income Statement

Balance Sheet

The company has $55.26 million in cash and $249,000 in debt, giving a net cash position of $55.01 million or $1.65 per share.

Cash & Cash Equivalents 55.26M
Total Debt 249,000
Net Cash 55.01M
Net Cash Per Share $1.65
Equity (Book Value) 54.47M
Book Value Per Share -6.18
Working Capital 50.60M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$42.85 million and capital expenditures -$802,000, giving a free cash flow of -$43.65 million.

Operating Cash Flow -42.85M
Capital Expenditures -802,000
Free Cash Flow -43.65M
FCF Per Share -$1.31
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MBX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -6.30%
FCF Yield -5.82%

Analyst Forecast

The average price target for MBX is $37.25, which is 65.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target $37.25
Price Target Difference 65.85%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1